Kevin Zarrabi

Also affiliated with Thomas Jefferson University Hospital, Sidney Kimmel Cancer Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes”.

Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes

Prostate Cancer and Prostatic Diseases(2024)10.1038/s41391-024-00797-0

N/A

0DataRank · unranked

23 citations

Allison Makovec, Andrew Elliott, Samuel Kellen, John R. Lozada, Ali T. Arafa +19 more

The Safety of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer: An Individual-Participant Data Meta-Analysis Based on 14 Randomized Clinical Trials

Cancers(2025)10.3390/cancers17172747

N/A

0DataRank · unranked

6 citations

Nikita Nikita, Swapnil Sharma, Scott W. Keith, Kevin Zarrabi, William K. Kelly +2 more

Exploring STEAP1 Expression in Prostate Cancer Cells in Response to Androgen Deprivation and in Small Extracellular Vesicles

Molecular Cancer Research(2025)10.1158/1541-7786.mcr-24-0903

N/A

0DataRank · unranked

4 citations

Camila A. Bach, Ricardo A. Santos, Cecilia E. Verrillo, Nicole M. Naranjo, Ishan Chaudhari +12 more

Use of GIP and GLP-1 receptor agonists in prostate cancer patients.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.5024

N/A

0DataRank · unranked

0 citations

Kevin Zarrabi, Nikita Nikita, William K. Kelly, Grace Lu‐Yao, Amy L. Shaver